Stephen L. Sacks

4.8k total citations · 1 hit paper
80 papers, 3.4k citations indexed

About

Stephen L. Sacks is a scholar working on Epidemiology, Infectious Diseases and Oncology. According to data from OpenAlex, Stephen L. Sacks has authored 80 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Epidemiology, 14 papers in Infectious Diseases and 13 papers in Oncology. Recurrent topics in Stephen L. Sacks's work include Herpesvirus Infections and Treatments (54 papers), Cytomegalovirus and herpesvirus research (30 papers) and Viral-associated cancers and disorders (11 papers). Stephen L. Sacks is often cited by papers focused on Herpesvirus Infections and Treatments (54 papers), Cytomegalovirus and herpesvirus research (30 papers) and Viral-associated cancers and disorders (11 papers). Stephen L. Sacks collaborates with scholars based in Canada, United States and Belgium. Stephen L. Sacks's co-authors include Lawrence Corey, Daniel T. Leung, Fred Y. Aoki, Spotswood L. Spruance, Lawrence R. Stanberry, Stephen K. Tyring, Martine Denis, Pierre Vandepapelière, Adrian Mindel and Gary Dubin and has published in prestigious journals such as New England Journal of Medicine, JAMA and Journal of Clinical Investigation.

In The Last Decade

Stephen L. Sacks

80 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Glycoprotein-D–Adjuvant Vaccine to Prevent Genital Herpes

2002 583 citations Lawrence R. Stanberry, Spotswood L. Spruance et al. New England Journal of Medicine profile →

Peers

Countries citing papers authored by Stephen L. Sacks

Since Specialization

Citations

This map shows the geographic impact of Stephen L. Sacks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen L. Sacks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen L. Sacks more than expected).

Fields of papers citing papers by Stephen L. Sacks

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen L. Sacks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen L. Sacks. The network helps show where Stephen L. Sacks may publish in the future.

Co-authorship network of co-authors of Stephen L. Sacks

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen L. Sacks. A scholar is included among the top collaborators of Stephen L. Sacks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen L. Sacks. Stephen L. Sacks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Inadequacy of Plasma Acyclovir Levels at Delivery in Patients With Genital Herpes Receiving Oral Acyclovir Suppressive Therapy in Late Pregnancy 2009 ·Journal of Obstetrics and Gynaecology Canada ·Daniel T. Leung, (unknown), Emily Wagner, (unknown), Anna Wald, Stephen L. Sacks, Lawrence Corey, Deborah Money	6
2	Topical Resiquimod 0.01% Gel Decreases Herpes Simplex Virus Type 2 Genital Shedding: A Randomized, Controlled Trial 2007 ·The Journal of Infectious Diseases ·Karen E. Mark, Lawrence Corey, Tze‐Chiang Meng, Amalia Magaret, Meei‐Li Huang, Stacy Selke, Herbert B. Slade, Stephen K. Tyring, Terri Warren, Stephen L. Sacks, Peter A. Leone, (unknown), Anna Wald	78
3	Comparative Efficacy of Famciclovir and Valacyclovir for Suppression of Recurrent Genital Herpes and Viral Shedding 2006 ·Sexually Transmitted Diseases ·Anna Wald, Stacy Selke, Terri Warren, Fred Y. Aoki, Stephen L. Sacks, Francisco Díaz‐Mitoma, Lawrence Corey	49
4	Evaluation of dendrimer SPL7013, a lead microbicide candidate against herpes simplex viruses 2005 ·Antiviral Research ·(unknown), Barry Matthews, Tom D. McCarthy, (unknown), George Holan, J. W. Raff, Stephen L. Sacks	70
5	Clinic-Initiated, Twice-Daily Oral Famciclovir for Treatment of Recurrent Genital Herpes: A Randomized, Double-Blind, Controlled Trial 2005 ·Clinical Infectious Diseases ·Stephen L. Sacks, F. Y. Aoki, Alain Martel, Stephen D. Shafran, M. Lassonde	19
6	Famciclovir Suppression of Asymptomatic and Symptomatic Recurrent Anogenital Herpes Simplex Virus Shedding in Women: A Randomized, Double‐Blind, Double‐Dummy, Placebo‐Controlled, Parallel‐Group, Single‐Center Trial 2004 ·The Journal of Infectious Diseases ·Stephen L. Sacks	19
7	Therapeutic options for herpes simplex infections 2003 ·Current Infectious Disease Reports ·(unknown), Stephen L. Sacks	1
8	Oral Famciclovir for the Suppression of Recurrent Genital Herpes: The Combined Data from Two Randomized Controlled Trials 2003 ·Journal of Cutaneous Medicine and Surgery ·Stephen K. Tyring, Francisco Díaz‐Mitoma, Stephen D. Shafran, Leslie Ann Locke, Stephen L. Sacks, Clarence L. Young	10
9	Glycoprotein-D–Adjuvant Vaccine to Prevent Genital Herpes breakdown → 2002 ·New England Journal of Medicine ·Lawrence R. Stanberry, Spotswood L. Spruance, Anthony L. Cunningham, David I. Bernstein, Adrian Mindel, Stephen L. Sacks, Stephen K. Tyring, Fred Y. Aoki, M. Slaoui, Martine Denis, Pierre Vandepapelière, Gary Dubin	583
10	Evidence of dual sites of action of dendrimers: SPL-2999 inhibits both virus entry and late stages of herpes simplex virus replication 2002 ·Antiviral Research ·Yunhao Gong, Barry Matthews, Dorothy Cheung, Teresa Tam, Izabelle Gadawski, Daniel T. Leung, George Holan, J. W. Raff, Stephen L. Sacks	67
11	Comparison of methods for identifying resistant herpes simplex virus and measuring antiviral susceptibility 2002 ·Journal of Clinical Virology ·Robert T. Sarisky, P. Crosson, (unknown), Matthew R. Quail, Tammy Nguyen, Robert J. Wittrock, Teresa H. Bacon, Stephen L. Sacks, L Caspers-Velu, Richard L. Hodinka, Jeffry J. Leary	15
12	Development and validation of a plasma assay for acyclovir using high-performance capillary electrophoresis with sample stacking 2002 ·Journal of Chromatography B ·(unknown), (unknown), Daniel T. Leung, Stephen L. Sacks	40
13	Preclinical evaluation of docusate as protective agent from herpes simplex viruses 2001 ·Antiviral Research ·Yunhao Gong, Aimin Wen, Dorothy Cheung, Michelle Wong, Stephen L. Sacks	12
14	Clinical efficacy of topical docosanol 10% cream for herpes simplex labialis: A multicenter, randomized, placebo-controlled trial 2001 ·Journal of the American Academy of Dermatology ·Stephen L. Sacks, Ronald A. Thisted, Terry M. Jones, Rick A. Barbarash, Dennis J. Mikolich, Gary Ruoff, Joseph L. Jorizzo, (unknown), David H. Katz, (unknown), Phillip R. Morrow, Gerald J. Yakatan, Laura E. Pope, (unknown)	75
15	Current Recommendations for the Treatment of Genital Herpes 2000 ·Drugs ·Daniel T. Leung, Stephen L. Sacks	59
16	Improving the Management of Genital Herpes 1999 ·Hospital Practice ·Stephen L. Sacks	3
17	Heterogeneity of a Herpes Simplex Virus Clinical Isolate Exhibiting Resistance to Acyclovir and Foscarnet 1992 ·Advances in experimental medicine and biology ·Emanuela Pelosi, Karen A. Hicks, Stephen L. Sacks, Donald M. Coen	9
18	Recombinant alpha-2 interferon gel treatment of recurrent herpes genitalis 1992 ·Antiviral Research ·Mark Lebwohl, Stephen L. Sacks, Marcus A. Conant, James D. Connor, John M. Douglas, Lawrence J. Eron, Steven I. Marlowe, Jack Mendelson, Virginia Chen, (unknown), (unknown), J. Richard Trout, Terry F. Plasse	15
19	Nucleic acid related compounds. 65. New syntheses of 1-(.beta.-D-arabinofuranosyl)-5(E)-(2-iodovinyl)uracil (IVAraU) from vinylsilane precursors. Radioiodine uptake as a marker for thymidine kinase herpes viral infections 1991 ·Journal of Medicinal Chemistry ·Morris J. Robins, Stefano Manfredini, Steven G. Wood, (unknown), (unknown), Stephen L. Sacks	23
20	Chronic Suppression for Six Months Compared With Intermittent Lesional Therapy of Recurrent Genital Herpes Using Oral Acyclovir 1988 ·Sexually Transmitted Diseases ·Stephen L. Sacks, (unknown), H Grant Stiver, S. Roland, Sandra Nusinoff-Lehrman, Ronald E. Keeney	21

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact